From wiki-pain
Revision as of 11:37, 21 September 2012 by Daniel (Talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Context Info
Confidence 0.60
First Reported 1989
Last Reported 1997
Negated 1
Speculated 1
Reported most in Abstract
Documents 3
Total Number 3
Disease Relevance 2.85
Pain Relevance 0.38

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

peptidase activity (C9orf3) cytoplasm (C9orf3)
C9orf3 (Homo sapiens)
Pain Link Frequency Relevance Heat
tolerance 2 89.20 High High
Angina 5 78.88 Quite High
headache 1 25.00 Low Low
Disease Link Frequency Relevance Heat
Disorder Of Lipid Metabolism 6 100.00 Very High Very High Very High
Coagulation Disorder 1 99.40 Very High Very High Very High
Atherosclerosis 7 99.12 Very High Very High Very High
Disease 3 97.24 Very High Very High Very High
Myocardial Infarction 2 97.24 Very High Very High Very High
Chronic Renal Failure 2 96.60 Very High Very High Very High
Impaired Glucose Tolerance 1 89.84 High High
Coronary Artery Disease 1 81.96 Quite High
Cv General 3 Under Development 5 78.88 Quite High
Increased Venous Pressure Under Development 4 78.80 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
During a year, increased "atherogenic" changes in the spectrum of Lp, apo were revealed in patients with a more severe clinical course of the disease as compared to an "instability" period; when the disease proceeded favourably, a "positive" time-course of these parameters was observed.
Regulation (changes) of apo associated with disease
1) Confidence 0.60 Published 1989 Journal Kardiologiia Section Abstract Doc Link 2615176 Disease Relevance 1.09 Pain Relevance 0.30
The aim of this study was therefore to investigate whether the LDL-unbound form of apo(a) contributes to the prediction of carotid atherosclerosis in a group of 153 hemodialysis patients.
Spec (whether) Regulation (contributes) of apo associated with atherosclerosis
2) Confidence 0.44 Published 1997 Journal Clin. Genet. Section Abstract Doc Link 9520130 Disease Relevance 1.08 Pain Relevance 0
Treatment did not significantly modify both lipid metabolism (triglycerides, total cholesterol, HDL, LDL, Apo A, Apo B) and clotting system (fibrinogen, PT, PTT, antithrombin III, fibrinopeptide A).
Neg (not) Regulation (modify) of Apo associated with coagulation disorder and disorder of lipid metabolism
3) Confidence 0.12 Published 1993 Journal Contraception Section Abstract Doc Link 8462314 Disease Relevance 0.68 Pain Relevance 0.08

General Comments

This test has worked.

Personal tools